Published in Blood Weekly, January 27th, 2011
"Recent findings MSCs strongly inhibited T-cell activity in vitro and exerted similar inhibitory effects on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.